Heart Disease in Pregnancy
Keywords:
Heart, Cardiovascular, Pregnancy treatmentAbstract
The update of medical technologies makes us live longer for examples the congenital heart
disease patients who died in large number in the past. But nowadays the morbidity and mortality
rate were decreased significantly after the development of surgical techniques, equipments
and better medicine in the last decade. Many patients who survive from the congenital defects
correction can now reach the fertility period and have capabilities to conceive babies. The overall
incidence of pregnancy with heart disease is 1% of pregnancies. Heart disease in pregnancies is a
common cause of maternal death in Western countries. Despite the development of modalities
of treatments on the heart disease, the women who have this coincidental illness will be
addressed as ‘mother at risk’ who may need special antepartum, intrapartum and postpartum
cares. Because these patients have many physiological changes in cardiovascular system which
impact on her underlying disease. The additional, heart disease will have negative effect on
pregnancy outcomes. The treatment plan for these patients should involve in multidisciplinary
and participation among health care team and families. The health care team should understand
the pathophysiology changes during pregnancy and ready for emergency situations.
References
Haulth JC, Rouse DJ, Spong CY. Williams
Obstertrics. 23rd ed. New York: The McGraw-
Hill Companies, Inc; 2010.
2. Perloff JK. Congenital heart disease and
pregnancy. Clin Cardiol. 1994; 17): 579-87.
3. Tolstrup K. Cardiovascular disease in
pregnancy [Electronic book]. New York: The
McGraw-Hill Companies, Inc; 2009. Available
from: www.mdconsult.com.
4. Perloff JK, Child JS, ABOULHOSN
J. Management of Pregnancy and
Contraception in Congenital Heart Disease.
In: Perloff JK CJ, Aboulhosn J, editor.
Congenital heart disease in adult. 3rd
ed. Philadelphia: Saunder. An Imprint of
Elservier; 2008.
5. Baldisseri MR. Cardiovascular and
endocrinology changes associated with
pregnancy. [Electronic book]. Philadelphia:
Saunder, An Imprint of Elservier; 2011.
Available from: www.mdconsult.com.
6. Sibai BM. Hypertension. In: Gabbe SG,
Niebyl JR, Simpson JL, Landon MB,
editors. Obstetrics: normal and problem
pregnancies. Philadelphia: Suanders, An
Imprint of Elsevier; 2012. p. 780-806.
7. Harris IS. Management of pregnancy in
patients with congenital heart disease. Prog
Cardiovasc Dis. 2011; 53: 305-11.
8. Thanajiraprapa T, Phupong V. Pregnancy
complications in women with heart disease.
J Matern Fetal Neonatal Med. 2010; 23:
1200-4.
9. Hameed Ab MMN. Cardiac & pulmonary
disorders in pregnancy. In: DeCherney AH,
Nathan L, Laufer N, Roman AS, editors.
Current diagnosis & treatment: obstetrics
& gynecology. 11 th ed. New York: The
McGraw-Hill; 2013.
10. McAnulty JH, Broberg CS, Metcalfe J. Heart
disease and pregnancy. In: Fuster V, Walsh
RA, Harrington RA, editors. Hurst’s the
heart. 13rd ed. New York: The McGraw-Hill;
2011.
11. Hameed Ab MMN. CHapter 27. cardiac &
pulmonary disorders in pregnancy; 2013.
12. Mohrman DE, Heller LJ. Cardiovascular
Physiology [Electronic book]. New York:
The McGraw-Hill; 2010 [cited 2014, 24 Feb].
Available from: www.accessmedicine.com.
13. Wilson W, Taubert KA, Gewitz M, Lockhart
PB, Baddour LM, Levison M, et al. Prevention
of infective endocarditis: guidelines from
the American Heart Association: a guideline
from the American Heart Association
Rheumatic Fever, Endocarditis, and
Kawasaki Disease Committee, Council on
Cardiovascular Disease in the Young, and
the Council on Clinical Cardiology, Council
on Cardiovascular Surgery and Anesthesia,
and the Quality of Care and Outcomes
Research Interdisciplinary Working Group.
Circulation. 2007; 116: 1736-54.
14. ACOG Practice Bulletin No. 74. Antibiotic
prophylaxis for gynecologic procedures.
Obstet Gynecol. 2006; 108: 225-34.
15. Secher NJ, Thayssen P, Arnsbo P, Olsen J.
Effect of prostaglandin E2 and F2alpha on
the systemic and pulmonary circulation
in pregnant anesthetized women. Acta
Obstet Gynecol Scand. 1982; 61: 213-8.
16. SCHIFFER MA, PAKTER J, CLAHR J. Mortality
Associated with Hypertonic Saline Abortion.
Obstetrics & Gynecology. 1973; 42: 759-64.
17. Castadot RG. Pregnancy termination:
techniques, risks, and complications and
their management. Fertil Steril. 1986; 45:
5-17.
18. Yeager DP, Toy EC, Baker Iii B. Influenza
Vaccination in Pregnancy. Amer J Perinatol.
2008; 16: 283-6.
19. Warnes CA, Williams RG, Bashore TM, Child
JS, Connolly HM, Dearani JA, et al. ACC/
AHA 2008 Guidelines for the Management
of Adults with Congenital Heart Disease:
a report of the American College of
Cardiology/American Heart Association
Task Force on Practice Guidelines (writing
committee to develop guidelines on the
management of adults with congenital
heart disease). Circulation. 2008; 118: 7.
20. กิตติ กรุงไกรเพชร. การรักษาผู้ป่วยปรีอีแคลมเซีย
แบบประคับประคอง. ธรรมศาสตร์เวชสาร 2553;
10: 193-200.
21. Hameed AB, Chan K, Ghamsary M, Elkayam
U. Longitudinal changes in the B-type
natriuretic peptide levels in normal
pregnancy and postpartum. Clin Cardiol.
2009; 32: 20391.
22. Tanous D, Siu SC, Mason J, Greutmann
M, Wald RM, Parker JD, et al. B-type
natriuretic peptide in pregnant women
with heart disease. J Am Coll Cardiol. 2010;
56: 1247-53.
23. Kale A, Kale E, Yalinkaya A, Akdeniz N,
Canoruc N. The comparison of aminoterminal
probrain natriuretic peptide
levels in preeclampsia and normotensive
pregnancy. J Perinat Med. 2005; 33: 121-4.
24. Resnik JL, Hong C, Resnik R, Kazanegra
R, Beede J, Bhalla V, et al. Evaluation of
B-type natriuretic peptide (BNP) levels in
normal and preeclamptic women. Am J
Obstet Gynecol. 2005; 193: 450-4.
